; Pharmaceutical Intermediates Market Size, Industry Share, Forecast, 2032

Pharmaceutical Intermediates Market

Pharmaceutical Intermediates Market: By Product (Chemical Intermediates, Bulk Drug Intermediates, Custom Intermediates), By Application (Analgesics, Anti-Inflammatory Drug, Cardiovascular Drugs, Anti-Diabetic Drugs, Antimicrobial Drugs, Anti-Cancer Drugs), By End User (Biotech and Pharma Companies, Research Laboratory, CMOs/CROs), And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032

Published on: Jan-2023
Report Code: FG HC 00764
No. of Pages: 170-350
Report Format: PDF

[170+ Pages Research Report] Pharmaceutical Intermediates Market to surpass USD 48.5 billion by 2032 from USD 29.06 billion in 2021 at a CAGR of 4.8% throughout the forecast period 2022-32

Product Overview

Pharmaceutical intermediates are the chemical compounds that are broadly used for the production of different kinds of drugs in large quantities. They are also required for research and development by pharmaceutical and biotechnology firms. Active pharmaceutical compounds are produced from pharmaceutical intermediates (APIs). When APIs are made, pharmaceutical intermediates are created as a by-product. Each reaction in the manufacturing of API results in the development of various pharmaceutical intermediates. It can only be converted into API with additional molecular alterations or improvements. Intermediates may or may not be separated. In addition to being employed by numerous pharmaceutical and biopharmaceutical businesses for R&D, pharmaceutical intermediates are also used in the manufacturing of bulk medications.

Market Highlights

The Pharmaceutical Intermediates Market is expected to project a notable CAGR of 4.8% in 2032.

Pharmaceutical Intermediates to surpass USD 48.5 billion by 2032 from USD 29.06 billion in 2021 at a CAGR of 4.8% in the coming years, i.e., 2022-32. The global Pharmaceutical Intermediates Market is growing as a result of the rising demand for pharmaceutical intermediates in the pharmaceutical and cosmetic sectors. In the pharmaceutical sector, research and development frequently use pharmaceutical intermediates. Over the forecast period, these factors are anticipated to drive the market.

Figure - Market Analysis of Pharmaceutical Intermediates Market


Get More Information - Download Free Sample

Pharmaceutical Intermediates Market: Segments

The Bulk Drug Intermediates segment is expected to grow with a higher CAGR during 2022-32

Pharmaceutical Intermediates Market is categorized on the basis of Product into Chemical Intermediates, Bulk Drug Intermediates, and Custom Intermediates. The bulk drug intermediates are anticipated to hold a larger global share throughout the projected period since they are used to create active pharmaceutical ingredients (API). The main component of medications that produces the intended therapeutic effect is called API. Moreover, it is predicted that government programs to support and build bulk drug parks would fuel the growth of this market.

The Analgesics segment is expected to grow with a higher CAGR during 2022-32

Pharmaceutical Intermediates Market is categorized on the basis of application into Analgesics, Anti-Inflammatory Drug, Cardiovascular Drugs, Anti-Diabetic Drugs, Antimicrobial Drugs, Anti-Cancer Drugs, and Others. The pharmaceutical intermediates market had a significant contribution from the analgesics segment. The segment is predicted to continue dominance in the near future as well since analgesics are often used to treat pain. This market is expanding as chronic conditions like arthritis, cancer, and cardiovascular disorders are becoming more common worldwide.

Figure - Market Analysis of Global Pharmaceutical Intermediates


Get More Information - Download Free Sample

Market Dynamics

Growth Drivers

The Rising Number of Chronic Diseases and Technological Improvements

The surge in demand for necessary medications to treat chronic diseases has a significant impact on the demand for pharmaceutical intermediates. The demand for pharmaceutical intermediates for research purposes is also rising as a result of developments in technologies, such as high throughput, bioinformatics, and combinatorial chemistry for better drug candidate discovery. Therefore, it is anticipated that the use of pharmaceutical intermediates would continue to increase over the projected period due to increased production and research efforts in the pharmaceutical sector.

The Growing Demand for Pharmaceutical Intermediates, especially from the Multiple Small and Medium Scale Companies

A number of small and medium-sized businesses are concentrating on increasing their production capacity, which is another driver anticipated to boost demand for pharmaceutical intermediates and subsequently drive the market. As a result, there is a growing need for pharmaceutical intermediate, and sales are expected to increase significantly through 2030. Major pharmaceutical firms are also increasingly using contract manufacturing firms to produce pharmaceutical intermediates and finished products.

Restraint

Strict Regulatory Policies and Significantly High Capital Investments for API Production

In the upcoming years, the growth of the Pharmaceutical Intermediate Market is anticipated to be slowed down by strict regulatory policies. Another important aspect that could adversely affect the market growth indirectly is the high cost of purchasing biopharmaceutical medications. Another aspect limiting the market growth is the high capital expenditures required to produce APIs.

Recent Developments
  • Amgen announced a 5-year, about US$ 3.5 billion capital investment in the United States, and in July 2018, it also revealed plans for a new US$ 300 million plant on campus in Greenwich, Rhode Island.
  • ACETO stated in February 2019 that it had sold the assets of its chemicals business to New Mountain Capital for $338 million.
  • Fine Industries Limited, together with its subsidiaries Fine Organics Ltd. and Fine Environmental Services Ltd.,llll were acquired by Lianhetech in July 2017.

Pharmaceutical Intermediates Market: Key Players
  • BASF SE

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • Sanofi
  • Pfizer
  • Evonik Industries AG
  • Arkema Inc
  • Vertellus Holdings LLC
  • Dishman Group
  • Aceto Corporation
  • Codexis Inc.
  • Midas Pharma GmbH
  • Interchem
  • Lonza Group
  • Chemcon Specialty Chemical Pvt. Ltd
  • Dextra Laboratories Limited
  • Chiracon GmbH
  • Other Prominent Players

Pharmaceutical Intermediates Market: Regions

Pharmaceutical Intermediates Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In terms of revenue, North America dominated the market for pharmaceutical intermediates globally in 2020, and it is anticipated that it will continue to do so during the projected period. Due to the large number of pharmaceutical companies, research facilities, and laboratories as well as the quickly expanding CMOs & CROs in the US and Canada, North America dominates the market. Also, increasing public and private sector investments in the biopharmaceutical sector are anticipated to keep North America in the lead during the projected period.

The Asia Pacific market is anticipated to grow at a remarkable CAGR. The region's market is expected to grow due to the increasing geriatric population.


Get More Information - Download Free Sample

Impact of Covid-19 on Pharmaceutical Intermediates Market

The growth of COVID-19 virus has increased the number of COVID-19 patients being admitted to hospitals, which has caused a scarcity of drug storage. Globally, a number of government agencies issued scarcity alerts for a number of medications, including possible COVID-19 therapies. The pandemic can have a variety of short- and long-term effects on the market for pharmaceutical intermediates, mostly due to constraints in the global supply chain that lead to a shortage of raw materials.

Pharmaceutical Intermediates Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Pharmaceutical Intermediates Market report also contains analysis on:

Pharmaceutical Intermediates Market Segments:

  • By Product 
    • Chemical Intermediates
    • Bulk Drug Intermediates
    • Custom Intermediates 
  • By Application 
    • Analgesics
    • Anti-Inflammatory Drug
    • Cardiovascular Drugs
    • Anti-Diabetic Drugs
    • Antimicrobial Drugs
    • Anti-Cancer Drugs
    • Others
  • By End User
    • Biotech and Pharma Companies
    • Research Laboratory
    • CMOs/CROs 
  • Pharmaceutical Intermediates Market Dynamics
  • Pharmaceutical Intermediates Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Pharmaceutical Intermediates Market Report Scope and Segmentation

REPORT ATTRIBUTE

DETAILS

Market Size Value in 2021

USD 29.06 billion

Revenue Forecast in 2032

USD 48.5 billion

Growth Rate

CAGR of 4.8% from 2022 to 2032

Base Year for Estimation

2021

Quantitative Units

Revenue in USD billion and CAGR from 2022 to 2032

Report Coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments Covered

Product, Application, End User, and Region

Regional Scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

Key Companies Profiled

BASF SE, Sanofi, Pfizer, Evonik Industries AG, Arkema Inc, Vertellus Holdings LLC, Dishman Group, Aceto Corporation, Codexis Inc., Midas Pharma GmbH, Interchem, Lonza Group, Chemcon Specialty Chemical Pvt. Ltd, Dextra Laboratories Limited, Chiracon GmbH, and Other Prominent Players.

Frequently Asked Questions (FAQ):

The Pharmaceutical Intermediates Market size was estimated at USD 29.06 billion in 2021 and is expected to reach USD 48.5 billion in 2032.

Pharmaceutical intermediates are the chemical compounds that are broadly used for the production of different kinds of drugs in large quantities.

The Bulk Drug Intermediates and Analgesics segments accounted for the larger share of the Pharmaceutical Intermediates Market.

Key players in the Pharmaceutical Intermediates Market are BASF SE, Sanofi, Pfizer, Evonik Industries AG, Arkema Inc, Vertellus Holdings LLC, Dishman Group, Aceto Corporation, Codexis Inc., Midas Pharma GmbH, Interchem, Lonza Group, Chemcon Specialty Chemical Pvt. Ltd, Dextra Laboratories Limited, Chiracon GmbH, and Other Prominent Players.

The global Pharmaceutical Intermediates Market is growing as a result of the rising demand for pharmaceutical intermediates in the pharmaceutical and cosmetic sectors.

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients